Abstract
BK virus (BKV) is an increasingly identified cause of pathology in immunocompromised transplant recipients. BKV is a well-known cause of graft dysfunction following renal transplantation and has also been reported in the native kidneys of other solid organ recipients. Less commonly, BKV nephropathy occurs in allogeneic stem-cell transplant (SCT) recipients. We now describe the first reported case of BKV nephropathy after pediatric autologous SCT.
Copyright © 2010 Wiley-Liss, Inc.
MeSH terms
-
Antineoplastic Agents / therapeutic use
-
BK Virus / pathogenicity*
-
Child
-
Combined Modality Therapy
-
Fatal Outcome
-
Female
-
Humans
-
Immunosuppressive Agents / therapeutic use
-
Nephritis, Interstitial / etiology*
-
Nephritis, Interstitial / therapy
-
Neuroectodermal Tumors, Primitive / complications*
-
Neuroectodermal Tumors, Primitive / therapy
-
Polyomavirus Infections / etiology*
-
Polyomavirus Infections / therapy
-
Stem Cell Transplantation / adverse effects*
-
Transplantation, Autologous
-
Tumor Virus Infections / etiology*
-
Tumor Virus Infections / therapy
Substances
-
Antineoplastic Agents
-
Immunosuppressive Agents